243 related articles for article (PubMed ID: 29408170)
21. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of pentraxin 3 in patients with spondyloarthritis.
Nisihara R; Skare TL; Zeni JO; Rasera H; Lidani K; Messias-Reason I
Biomarkers; 2018 Feb; 23(1):14-17. PubMed ID: 28043168
[TBL] [Abstract][Full Text] [Related]
23. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
[TBL] [Abstract][Full Text] [Related]
24. Pentraxin 3 inhibits fibroblast growth factor 2 induced osteoclastogenesis in rheumatoid arthritis.
Zhao S; Wang Y; Hou L; Wang Y; Xu N; Zhang N
Biomed Pharmacother; 2020 Nov; 131():110628. PubMed ID: 32890968
[TBL] [Abstract][Full Text] [Related]
25. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
26. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Deyab G; Hokstad I; Whist JE; Småstuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I
PLoS One; 2017; 12(2):e0169830. PubMed ID: 28225768
[TBL] [Abstract][Full Text] [Related]
27. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
[TBL] [Abstract][Full Text] [Related]
28. Increased serum pentraxin 3 in patients with systemic sclerosis.
Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
[TBL] [Abstract][Full Text] [Related]
29. The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.
Duran L; Unsal M; Yardan T; Kati C; Bedir A; Turkeli S; Ekiz M
Clin Lab; 2015; 61(12):1911-6. PubMed ID: 26882815
[TBL] [Abstract][Full Text] [Related]
30. Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.
Otsubo H; Tsuneyoshi Y; Nakamura T; Matsuda T; Komiya S; Matsuyama T
Clin Rheumatol; 2018 Nov; 37(11):2939-2945. PubMed ID: 30022370
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein.
Kumon Y; Loose LD; Birbara CA; Sipe JD
J Rheumatol; 1997 Jan; 24(1):14-9. PubMed ID: 9002005
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis.
Wen W; Li Y; Cheng Y; He J; Jia R; Li C; Guo J; Sun X; Li Z
Clin Exp Rheumatol; 2018; 36(2):233-240. PubMed ID: 28850019
[TBL] [Abstract][Full Text] [Related]
34. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
[TBL] [Abstract][Full Text] [Related]
36. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection.
Azzurri A; Sow OY; Amedei A; Bah B; Diallo S; Peri G; Benagiano M; D'Elios MM; Mantovani A; Del Prete G
Microbes Infect; 2005 Jan; 7(1):1-8. PubMed ID: 15716076
[TBL] [Abstract][Full Text] [Related]
38. The long pentraxin PTX3: a novel serum marker to improve the prediction of osteoporosis and osteoarthritis bone-related phenotypes.
Visconti VV; Greggi C; Fittipaldi S; Casamassima D; Tallarico M; Romano F; Botta A; Tarantino U
J Orthop Surg Res; 2021 Apr; 16(1):288. PubMed ID: 33931080
[TBL] [Abstract][Full Text] [Related]
39. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
40. Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.
Gul CB; Yildiz A; Ersoy A; Kahvecioglu S; Asiltas B; Yildirim F; Ermurat S; Sag S; Oruc A; Gullulu S; Gullulu M
Int Urol Nephrol; 2015 Jul; 47(7):1187-94. PubMed ID: 26047596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
